Scyllo-Inositol-d6
Scyllo-Inositol-d6 is the deuterium labeled Scyllo-Inositol (HY-W010041) . Scyllo-Inositol is an inhibitor that targets the aggregation of misfolded proteins (such as α-synuclein and Amyloid-β), is orally effective, and can cross the blood-brain barrier. Scyllo-Inositol can selectively bind to and stabilize non-toxic oligomers, preventing them from converting into toxic fibers, exerting protein homeostasis regulation and neuroprotective activity. Scyllo-Inositol binds to the hydrophobic region of pathogenic proteins, inhibits protein aggregation, and promotes lysosome- and proteasome-mediated degradation pathways, thereby reducing neurotoxicity. Scyllo-Inositol can be used in the study of neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, and Huntington's disease[1][2][3].
Product Specifications
CAS Number
[115268-26-3]
UNSPSC
12352211
Target
Amyloid-β; Isotope-Labeled Compounds; α-synuclein
Related Pathways
Neuronal Signaling; Others
Field of Research
Neurological Disease
Smiles
[2H][C@]1([C@@]([2H])(O)[C@]([2H])(O)[C@@](O)([C@@]([2H])([C@]1(O)[2H])O)[2H])O
Molecular Formula
C6H6D6O6
Molecular Weight
186.19
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items